ibs_diagnostic_score
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
ibs_diagnostic_score [2021/10/28 17:06] laura [Publications] |
ibs_diagnostic_score [2021/12/22 09:08] (current) trynke |
||
|---|---|---|---|
| Line 7: | Line 7: | ||
| \\ | \\ | ||
| ===== Background ===== | ===== Background ===== | ||
| - | To identify participants who get a positive Irritable Bowel Syndrome (IBS) diagnostic score based on the ROME III the researchers used the article from [[https://doi.org/10.1053/j.gastro.2006.03.008|Drossman, D. A. (2006)]]. In contrast to the article one criteria with respect to the occurrence of symptoms was adjusted in accordance to the ROME III of Lifelines, i.e. participants should indicate that they have recurrent abdominal pain or discomfort at least 1 day per week (instead of 3 days per month), with a symptom onset at least 6 months in the past. For women, this abdominal pain or discomfort should not only occur during menstrual bleeding. | + | To identify participants with a positive Irritable Bowel Syndrome (IBS) diagnostic score based on the ROME III the researchers used the article from [[https://doi.org/10.1053/j.gastro.2006.03.008|Drossman, D. A. (2006)]]. In contrast to the article one criteria with respect to the occurrence of symptoms was adjusted in accordance to the ROME III of Lifelines, i.e. participants should indicate that they have recurrent abdominal pain or discomfort at least 1 day per week (instead of 3 days per month), with a symptom onset at least 6 months in the past. For women, this abdominal pain or discomfort should not only occur during menstrual bleeding. |
| \\ | \\ | ||
| \\ | \\ | ||
| Line 56: | Line 56: | ||
| ===== Variables ===== | ===== Variables ===== | ||
| | **Label English** | **Label Dutch** | **Code** | **Variable** | **Assessment** | **Age** | | | **Label English** | **Label Dutch** | **Code** | **Variable** | **Assessment** | **Age** | | ||
| - | | Participant fulfills ROMEIII criteria for Irritable Bowel Syndrome (IBS) | Deelnemer voldoet aan ROMEIII criteria voor prikkelbare darm syndroom (PDS) | ibs_rome3_adu_c_1 | IBS_ROME3 | [[2a_questionnaire_2|2A]] [[3a_questionnaire_1|3A]] | 18+ | | + | | Participant fulfills ROME3 criteria for Irritable Bowel Syndrome (IBS) | Deelnemer voldoet aan ROME3 criteria voor prikkelbare darm syndroom (PDS) | ibs_rome3_adu_c_1 | IBS_ROME3 | [[2a_questionnaire_2|2A]] [[3a_questionnaire_1|3A]] | 18+ | |
| \\ | \\ | ||
| ===== Publications ===== | ===== Publications ===== | ||
| * [[https://doi.org/10.1126/scitranslmed.aap8914|Vila, A. V., Imhann, F., Collij, V., Jankipersadsing, S. A., Gurry, T., Mujagic, Z., ... & Weersma, R. K. (2018). Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Science translational medicine, 10(472).]] | * [[https://doi.org/10.1126/scitranslmed.aap8914|Vila, A. V., Imhann, F., Collij, V., Jankipersadsing, S. A., Gurry, T., Mujagic, Z., ... & Weersma, R. K. (2018). Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Science translational medicine, 10(472).]] | ||
ibs_diagnostic_score.1635433561.txt.gz ยท Last modified: 2021/10/28 17:06 by laura
Page Tools
Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Noncommercial-Share Alike 4.0 International
